Trinity Biotech
TRIB
48 hedge funds and large institutions have $76M invested in Trinity Biotech in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 10 closing their positions.
0.08% more ownership
Funds ownership: 3.06% → 3.15% (+0.08%)
7% less capital invested
Capital invested by funds: $81.5M → $76M (-$5.44M)
8% less funds holding
Funds holding: 52 → 48 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
44% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 16
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$3.42M |
| 2 |
Morgan Stanley
New York
|
+$1.58M |
| 3 |
Renaissance Technologies
New York
|
+$621K |
| 4 |
SM
Senvest Management
New York
|
+$575K |
| 5 |
State Street
Boston,
Massachusetts
|
+$543K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$1.29M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$880K |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$688K |
| 4 |
D.E. Shaw & Co
New York
|
-$614K |
| 5 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$599K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
51
Proxima Capital Management
New York
| – | -$165K | -5,875 | Closed |
|
|
OAM
52
Oxford Asset Management
Oxford,
United Kingdom
| – | -$105K | -3,762 | Closed |
|
|
BO
53
BRR OpCo
Columbus,
Ohio
| – | -$79K | -2,827 | Closed |
|
|
MCC
54
Malaga Cove Capital
Pv Estates,
California
| – | -$31K | -1,140 | Closed |
|
55
Citigroup
New York
| – | -$2.58K | -100 | -99% |
|
|
AIM
56
Advantage Investment Management
Cedar Rapids,
Iowa
| – | -$2K | -60 | Closed |
|
|
FDCDDQ
57
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$1.4K | -50 | Closed |
|
58
Simplex Trading
Chicago,
Illinois
| – | +$490 | +19 | New |
|
TRIB Hedge Fund Activity: Q4 2017 in Review
48 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q4 2017, worth a combined $76M — down 6.7% from $81.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TRIB and 6 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 9 added.
The largest buyer was Russell Investments Group, adding an estimated $3.42M. The largest seller was Parametric Portfolio Associates, exiting entirely with an estimated $1.29M sold.
- 48 institutional investors held Trinity Biotech (TRIB) as of Q4 2017, down from 52 in Q3 2017.
- Funds reported $76M of Trinity Biotech stock for Q4 2017, down 6.7% quarter-over-quarter.
- 6 funds opened new Trinity Biotech positions in Q4 2017 and 10 closed out, a net change of -4 holders.
- The largest Trinity Biotech buyer in Q4 2017 was Russell Investments Group, an estimated $3.42M added.
- The largest Trinity Biotech seller in Q4 2017 was Parametric Portfolio Associates, an estimated $1.29M sold.
Based on aggregated 13F filings for Q4 2017.